|
INTERNATIONAL BULLETIN JANUARY 2026 |
|
|
|
The international projects office of the IIS AragΓ³n has created this monthly newsletter through which it will inform about the calls for projects that are open, the events and the conferences that may be interesting in this regard for the research and management staff.
If you want to contact the international projects office you can do so through this email address: international@iisaragon.es. |
|
| | |
| | | ERC Consolidator Grants 2025
ERC-2026-CoGThese grants are open to researchers of any nationality with 7-12 years of experience since completing their doctorate.
ERC Consolidator Grants are designed to support outstanding Principal Investigators who are at a stage in their career where they may still be consolidating their own independent research team or programme. Principal Investigators must demonstrate the innovative character, ambition and feasibility of their research proposal.
More information in this link.
Closing date: 13/01/2026
To support applications for these calls, the agency ERC has recorded the webinar on the basic concepts of the Work Programme (WP) 2026. |
|
|
|
|
|
|
|
|
|
|
|
| | | | Cluster 1 Health β Single stage
Destination β Staying healthy in a rapidly changing society.
β’ HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioral interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people.
β’ HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences.
Destination β Living and working in a health-promoting environment
β’ HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health.
β’ HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems.
β’ HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research.
Destination β Tackling diseases and reducing disease burden
β’ HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults.
β’ HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions.
β’ HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential.
β’ HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximizing collaboration and coordination with sectors and in settings beyond the healthcare system (GACD).
β’ HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways.
β’ HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health.
Destination β Ensuring equal access to innovative, sustainable, and high-quality healthcare
β’ HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalized approaches.
β’ HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems.
β’ HORIZON-HLTH-2026-04-CARE-04: Enhancing and enlarging the European Partnership on Personalized Medicine (EP PerMed) (Top-up).
Destination β Developing and using new tools, technologies and digital solutions for a healthy society
β’ HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing.
β’ HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine.
β’ HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices.
β’ HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centers of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs).
Destination β Maintaining an innovative, sustainable, and competitive EU health industry
β’ HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centered health technologies.
More Information
Closing date: 16/04/2026
Destination β Tackling diseases and reducing disease burden
β’ HORIZON-HLTH-2026-02-DISEASE-12: European Partnership on Rare Diseases (ERDERA) (Phase 2).
Closing date: 15/09/2026 |
|
| | | MISSION SOIL β ONE HEALTH WP2026
β’ HORIZON-MISS-2026-05-SOIL-02: Antimicrobial resistance and antibiotic biosynthesis in soils: developing key understanding and counteractive strategies using a One-Health approach.
Closing date: 15/09/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | | | Trials4Health: Multi-country Investigator-Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases
The European association ERA4Health has launched its seventh Joint Transnational Call (JTC 2026), Trials4Health, aimed at funding investigator-initiated multicenter clinical trials (IICS) in cardiovascular, autoimmune and metabolic diseases.
The objective is to support pragmatic randomized studies comparing the effectiveness and/or repurposing of drugs, promoting transnational collaboration between clinical and public health teams.
Learn more.
Deadline to contact ECRIN representatives (for applications with additional funding): 30/11/2025
Pre-proposal closing date: 27/01/2026
Deadline for submitting complete proposals: 17/06/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | Understanding and Preventing Overweight and Obesity: Mechanisms of their onset and progression, neglected determinants and novel strategies for critical transitional periods in life β PREVENT-OO
The aim is to promote multidisciplinary and transnational projects that:
β’ Delve deeper into the biological mechanisms of obesity and its complications, and/or
β’ Develop public health strategies aimed at critical life transition stages, influenced by biological or socio-environmental changes.
More Information
Pre-proposal closing date: 21/01/2026
Deadline for submitting complete proposals: 10/06/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | EP PerMed: Research Innovation and Technology Call for Proposals (RITC) 2026
Test and Demonstration of Multimodal Data Approaches for Personalized Medicine (MultiPMData2026)
This call seeks to bring together companies and clinical stakeholders (healthcare providers, patients, and researchers) to test innovative solutions in controlled, real-world settings, with the goal of improving the management of multimorbidity.
EP PerMed will fund projects focused on the use of multimodal data to provide more efficient and personalized management for patients with at least two chronic diseases. Projects must test and develop mature solutions in real-world settings, adopt a systemic approach, and integrate six key elements (knowledge, technology, infrastructure, business models, policies, organization, and values). Proposals must include a clear strategy for multimodal health data management.
Consortia must have a clinical partner and at least one SME or industrial partner. Clinical studies can be funded, but not large clinical trials.
Closing date for the first phase: 12/01/2026
Closing date for the second phase: 27/04/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | EP PerMed: Personalized Medicine for CARdiovascular, MEtabolic, and kidney diseases (CARMEN2026)
The objective of this call is to fund transnational research projects in human health on innovative personalized medicine strategies for patients with cardiovascular, metabolic or renal diseases.
More Information
Closing date for the first phase: 10/02/2026
Closing date for the second phase: 09/06/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | Twinning Call 2026 - Advancing Collaborative Implementation of Personalized Medicine Approaches in Healthcare
The European initiative EP PerMed has launched the 2026 Twinning Call, aimed at accelerating the transfer of personalized medicine solutions between institutions in different countries through Twinning partnerships. These partnerships facilitate the exchange of best practices and capabilities in personalized medicine, with a direct impact on patient care. The call offers funding of up to β¬50.000 per partnership for exchange activities lasting 6β12 months and requires transnational consortia composed of one donor and one or two recipients. A matchmaking webinar (January 15, 2026) has been organized to help interested parties connect with potential partners and present their approaches or needs in personalized medicine before preparing their proposals. The matchmaking period is now open, and details of the call, eligibility criteria, and full timeline are available. here.
Closing date: 26/02/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | EP PerMed β the 2nd Fast Track Call
Support to accelerate the validation and adoption of innovative personalized medicine solutions.
More Information
Closing date: 10/03/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | First joint transnational calls for proposals from the BrainHealth partnership
The aim of these calls is to promote research into the biological, social and environmental factors that influence the trajectory of brain health throughout life, with two calls for proposals:
Pre-proposal closing date: 10/03/2026
Deadline for submitting complete proposals: 30/06/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | Joint transnational call 2026: New treatments to tackle AMR
The aim of this call is to improve therapeutic success rates in patients, animals, and plants affected by bacterial or fungal infections, offering new treatment options and, at the same time, reducing the risk of resistance emerging in the various settings of the approach.One healthΒ».
The call is co-financed by the European Union and has the participation of 37 funding organizations from 28 countries, with a total estimated budget of over 31 million euros.
Also participating in this call for proposals, as national and regional funding bodies, are the Aragonese Institute of Health Sciences (IACS), The State Research Agency (AEI) And the Carlos III Health Institute (ISC III).
Partner search tool available in this link
More Information
Closing date: 02/02/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | JTC 2026 - Access to Care
The European Association Transforming Health and Care Systems (THCS) has launched its fourth Joint Transnational Call (JTC 2026), aimed at funding research and innovation projects focused on ensuring equitable access to health and care services, as well as providing policymakers and decision-makers with the tools and evidence to implement an efficient redistribution of resources in transforming healthcare systems. This call involves 32 funding agencies, with an indicative budget of β¬35 million (In Spain: the Andalusian Regional Government's Ministry of Health and Consumer Affairs, the MarquΓ©s de Valdecilla Research Institute, and the Carlos III Health Institute).
The selected projects must propose innovative solutions that contribute to reducing inequalities in access to and use of health and care services, through new financial models, innovative service delivery models, and interdisciplinary integrated care programs.
More Information
Pre-proposal closing date: 02/02/2026
Closing date for complete proposals: 30/06/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | ERDERA β Joint Transnational Call 2026: Resolving unsolved cases in rare genetic and non-genetic diseases
The European Rare Diseases Research Alliance (ERDERA) is launching its joint transnational call for proposals in December 2026, "Resolving unsolved cases in rare genetic and non-genetic diseases".
The call focuses on providing diagnostic clarity to cases of rare diseases, both genetic and non-genetic, that remain undiagnosed despite previous studies.
Areas of interest (examples):
β’ Identification and functional validation of variants of uncertain meaning.
β’ Integrated multi-omics approaches and advanced bioinformatics and AI tools.
β’ Modeling of disease mechanisms and use of clinical, environmental and sensor data.
More Information
Pre-proposal closing date: 12/02/2026
Deadline for submitting complete proposals: 08/07/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | Networking Support Scheme (NSS)
Ongoing call for proposals to fund international networking events on rare diseases and rare cancers. The program supports up to β¬30.000 per event, aimed at strengthening research networks, promoting knowledge exchange, and encouraging the participation of underrepresented countries (UCs).
You can apply to researchers, clinicians, research managers, and patient organizations. Each event must include participants from at least three eligible countries and must have at least one applicant from a UC country.
The application period is open continuously until 2029, with semi-annual evaluations.
Documentation and application submission are available on the platform. NSS of ERDERA.
Current round closing date: 07/04/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | IHI Call 12 β Driving innovation for a competitive European health ecosystem
The European Innovative Health Initiative (IHI JU) has published the final version of the text for IHI Call 12, scheduled for launch in early 2026. This single-phase call is aligned with the Strategic Research and Innovation Agenda (SRIA) and is based on an applicant-led approach. Projects must address unmet public health needs through ambitious, cross-sectoral public-private partnerships with a clear impact on society, the economy, and science. As with previous IHI calls, at least 50% of the budget must be covered by in-kind contributions from industry. The final call themes are detailed below:
β’ HORIZON-JU-IHI-2026-12-SINGLE-STAGE-01: Driving innovation for a better understanding of the determinants of health.
β’ HORIZON-JU-IHI-2026-12-SINGLE-STAGE-02: Boost innovation through better integration of fragmented health R&D efforts.
β’ HORIZON-JU-IHI-2026-12-SINGLE-STAGE-03: Driving innovation for people-centered integrated healthcare solutions.
β’ HORIZON-JU-IHI-2026-12-SINGLE-STAGE-04: Driving innovation by leveraging digitization and data sharing in healthcare.
β’ HORIZON-JU-IHI-2026-12-SINGLE-STAGE-05: Driving innovation for better assessment of the added value of innovative integrated healthcare solutions.
More Information
Closing date: 21/04/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | Be Ready β European Partnership for Pandemic Preparedness (pre-announcement)
The European Partnership for Pandemic Preparedness β BE READY announces the pre-launch of its first Joint Transnational Call, to be published in early January 2026. This call will support multinational, interdisciplinary, and innovative projects aimed at improving the understanding of host-pathogen dynamics to more effectively address emerging diseases with pandemic potential. Responding to the need for pan-European collaborative research in pandemic preparedness, the initiative seeks to consolidate an R&D ecosystem capable of anticipating, preventing, and mitigating future health crises through One Health approaches and international cooperation. Full details, including participating funders and eligibility rules, will be published alongside the call. link. |
|
|
|
|
|
|
|
|
|
|
|
| | | | | OTHER PROGRAMMES OF THE EUROPEAN COMMISSION |
|
|
|
|
|
|
|
|
|
|
|
| | DIGITAL EUROPE
β’ DIGITAL-2026-AI-09-DS-HEALTH-STORAGE: Health: Data ingestion capacities and data services for the European Genomic Data Infrastructure in the European Health Data Space: data storage and processing capacity.
β’ DIGITAL-2026-AI-09-DS-HEALTH-TOOL: Health: Data ingestion capacities and data services for the European Genomic Data Infrastructure in the European Health Data Space: data tools.
β’ DIGITAL-2026-AI-09-SOLUTIONS-CANCER-STEP: Deployment of cutting-edge multi-modal AI-based solutions in medical imaging.
Closing date: 03/03/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | ERASMUS +
β’ Cooperation partnerships in higher education (KA220-HED) This action enables participating organizations to gain experience in international cooperation and to strengthen their capacities, but also to produce high-quality innovative deliverables. The primary goal of Cooperation Partnerships is to allow organizations to increase the quality and relevance of their activities, to develop and reinforce their networks of partners, to increase their capacity to operate jointly at transnational level, boosting internationalization of their activities and through exchanging or developing new practices and methods as well as sharing and confronting ideas.
Closing date: 05/03/2026
β’ ERASMUS-EDU-2026-PI-ALL-INNO-BLUEPRINT: Alliances for Sectoral Cooperation on Skills (implementing the βBlueprintβ)
Closing date: 10/03/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | | | EW AI THRASHER AWARDS - FALL CYCLE 2026
This call for proposals aims to reward projects that apply innovative approaches to problems affecting the field of pediatrics, focusing on any disease or topic within this area. Priority will be given to innovative solutions that are easy to implement and close to clinical applicability.
Applicants must:
β’ Be institutions from any country. β’ Submit projects led by a principal investigator of any nationality, with a doctoral degree and the skills and experience necessary to carry out the proposed project.
*If the project includes activities carried out in a country other than that of the PI, a co-PI of the project must be assigned in each country.
The application will be made electronically through the application application.
More Information
Concept Paper Closing Date: 13/01/2026 (Fall Cycle) - 14/07/2026 (Spring Cycle)
Closing date for complete proposals: 30/04/2026 (Fall Cycle) |
|
|
|
|
|
|
|
|
|
|
|
| | IFCAH 2026
This call aims to promote academic research on Congenital Adrenal Hyperplasia (CAH).
Specific objectives:
β’ Proposal of new therapeutic targets and protocols. β’ Increase knowledge about the pathophysiology of CAH. β’ Prevention, diagnosis and treatment of natural or iatrogenic complications. Applicants must: β’ Submit one project per research team. β’ Have an MD, Ph.D., or equivalent academic degree. β’ Hold an equivalent professorship at a university, medical school, or comparable institution.
The application will be made by sending the expression of interest to the email address cfp@ifcah.org.
More Information
Closing date for expressions of interest: 15/01/2026
Closing date for complete proposals: April 2026 |
|
|
|
|
|
|
|
|
|
|
|
| | TRAMPOLINE GRANTS 2026
Through this call, basic research projects (Scientific call) or clinical research projects (Medical call) in the field of neuromuscular disorders will be funded.
This scholarship is intended to support:
β’ Young researchers in the early stages of their professional career (with permanent or temporary positions), β’ Innovative or high-risk projects in their early stages, but with potential for innovation. For these projects, providing preliminary data is not mandatory.
Applicants must be young researchers with a doctoral degree obtained within the last ten years.
It is recommended to include a French institution as part of the proposal.
The application process must be completed through the application platform (see link).
More Information
Closing date for expression of interest: 20/01/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | RESEARCH GRANTS 2026
This call for proposals will fund research projects on multiple sclerosis aimed at halting disease progression, preventing the disease, or improving patients' quality of life. Projects may be applied research, clinical or non-clinical, including projects on rehabilitation, care, and patient management.
The proposals must be relevant to the National Multiple Sclerosis Society research priorities.
Applicants must:
β’ Possess an MD, PhD or equivalent. β’ Be considered eligible by your institution to apply for grant support.
Incompatibilities:
Postdoctoral fellows, residents, and individuals in mentoring positions are not eligible.
The application will be made electronically through the application platform in two phases.
More Information
Pre-proposal closing date: 21/01/2026
Closing date for complete proposals: 28/01/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | INTER-LOCAL: International clinical trials in rare or difficult-to-treat cancers
The INTER-LOCAL call for proposals is now open for its first edition, aiming to promote international multicenter clinical trials (phase II or III) focused on local treatments based on surgery or radiotherapy for rare cancers or cancers with low survival rates. The AECC Scientific Foundation, together with funding entities from Belgium, the Netherlands, Sweden, and Norway, seeks to support collaborative projects that improve treatment options for these patients.
Consortia with at least three participating funding countries may apply for funding; additional centers in other countries may be included to expedite recruitment. Proposals must originate from the academic or clinical field and require active patient participation in their design and implementation.
More Information
Closing date: 22/01/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | FRAXA FELLOWSHIPS 2026
This call for proposals will fund research projects with a translational or preclinical focus on Fragile X, with the potential to produce an improvement in the treatment of this disease.
The funding provided must be used for hiring staff with postgraduate experience related to the project, as well as for other research costs.
Applications must:
β’ Be carried out by a non-profit university, hospital or laboratory, regardless of its location. β’ Submit a maximum of one application per research group. β’ Demonstrate that the IP has the full funding for the proper development of the project.
More Information
Closing date: 01/02/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | EFSD AND NOVO NORDISK A/S PROGRAMME FOR DIABETES RESEARCH IN EUROPE 2026
This call for proposals will fund a project aimed at promoting research into diabetes, and proposals may be submitted from:
1. Basic research. 2. Clinical research.
Applicants must:
1. Submit the application from one or more non-profit institutions located in Europe or in associated countries (according to the list of eligible countries).
2. Demonstrate that both the PI and any co-investigator maintain a formal link with the institution submitting the application.
The application will be made through the application link (see link) attaching the following documentation:
β’ Research plan. β’ Signatures and declaration. β’ Evidence of the institution's non-profit status. β’ Biographical sketch of the IP. β’ Biographical sketch of the co-investigator. β’ Collaboration Agreements. β’ List of abstracts of any current or pending support.
More Information
Closing date: 02/02/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | NEW INVESTIGATOR RESEARCH GRANT PROGRAM 2026
This call will allow researchers in relatively early stages of their careers to carry out research projects with potential impact on leukemia research.
The grant covers expenses related to the execution of the project, not the PI's salary.
Requirements. Applicants must:
β’ Please note that applicants do not need to be U.S. citizens. Research projects from outside the United States are welcome.
β’ Hold a position as an independent researcher in a non-profit academic entity at the time of application.
β’ Applicants must be researchers with less than seven years in their first position as an independent researcher at the start date of the grant. Years as resident physicians, fellows, or postdoctoral fellows are considered training years and are not included in the seven-year calculation. Adjustments may be made for career interruptions (e.g., family leave, military service, or illness).
More Information
Pre-proposal closing date: 06/02/2026
Closing date for complete proposals: 13/04/2026 |
|
|
|
|
|
|
|
|
|
|
|
| | | 19-20/01/2026 IHI Curious about Call 12? Join its info webinars!
The Innovative Health Initiative (IHI) will hold its IHI Call Days for Call 12 on January 19 and 20, 2026, in an online format. These webinars will provide key information about the call: financial aspects, participation guidelines, procedures, and general guidance for preparing competitive proposals.
The IHI 12 call invites innovative projects that address key health challenges in Europe and respond to patient needs, in line with IHI's Strategic Research and Innovation Agenda (SRIA). This is a single-stage call, meaning that proposals must guarantee that at least 50% of project costs are covered by in-kind contributions from IHI's industry members and, where applicable, contributing partners.
Registration
20/01/2026 Horizon Europe info days β EU Missions β Cancer
On January 20, 2026, the European Commission will organize Info Days dedicated to Horizon Europe Missions for the upcoming 2026 calls for proposals. In a 100% online format, funding opportunities linked to all European missions, including the Cancer mission, will be presented.
Participation offers an excellent opportunity to learn in detail about the thematic challenges, the rules of participation and cross-cutting synergies, as well as to advance the planning of international collaborative proposals.
More information and registration coming soon at the following link link
20/01/2026 Introductory Webinar EP PerMed Fast Track Validation Program 2026
A webinar to review the EP PerMed Fast Track 2026 Call and answer any questions about the call, the application process or the project.
More information and registration coming soon at the following link link
26-30/01/2026 Cluster Health Horizon Europe Brokerage Event 2026
From January 26 to 30, 2026, the Horizon Europe Health Cluster Brokerage Event will take place, organized by HNN 3.0, the European Commission, and the Enterprise Europe Network. This event aims to facilitate the creation of consortia for the 2026 calls of the 2026-2027 Health Work Programme. This international meeting, held before the Cluster Health INFODAY on February 10, 2026, gives interested parties more time to identify partners and prepare competitive proposals.
The event is free, but requires registration and profile activation, including at least one collaboration offer or request in the Marketplace section, aligned with the topics of interest. Registration must be completed in English, and profile validation may require adjustments requested by the organizers.
Target audience: entities eligible for Horizon Europe (universities, research centers, companies, hospitals, public administrations, NGOs, patient associations, etc.).
Registration
03/02/2026 Horizon Europe Information Day: Health Cluster and Cancer Mission
The IIS AragΓ³n, together with the Foundation for Health Training and Research of the Region of Murcia (FFIS), are preparing an online event for February 3rd (approx. 13h) to present the 2026-2027 work program of Horizon Europe focused on the Health Cluster and the Cancer Mission.
In the coming days we will send you more information and the link to join the event.
05/02/2026 Global Health EDCTP3 - Info Day 2026
The Global Health EDCTP3 partnership is holding its 2026 Info Day online. The event will offer a detailed overview of the topics in the 2026 Work Programme, application procedures, evaluation criteria, and a live Q&A session with partnership representatives.
The event will also include online networking sessions to identify partners and explore collaborations in global health research. Registered participants will gain immediate access to the EDCTP3 networking platform, where they can already present project ideas and showcase their group's expertise.
Registration
10/02/2026 Webinar Cluster 1 Health INFODAY 2026 (European Commission)
Virtual information session on Horizon Europe β Cluster 1 Health, where the European Commission will present the 2026 topics of the 2026β2027 Work Programme. The scientific and technical content of the calls for proposals, the rules for participation and evaluation, and a Q&A session will be held. Time: 08:00β16:00 CET.
More Information |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
